Schedule 13G ownership disclosure

BENITEC BIOPHARMA INC

Security class unavailable · CUSIP: 08205P100

Event date: 2021-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
1.5300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-22-001861
Form type
SC 13G/A
Filer
ALPHA CAPITAL ANSTALT
CIK
CIK 1140358
Filed
Jan 13, 2022
Reporting period
Dec 31, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub